Supplemental material - Treat-to-Target in the Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Canadian perspective

Name: Supplemental material - Treat-to-Target in the Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Canadian perspective
Creator: Jensen Yeung
Published: 2023-03-16T08:53:35.993Z
Keywords: Atopic Dermatitis, Eczema, Pruritus

Yeung, Jensen; Gooderham, Melinda; Hong, Chih-Ho; Lynde, Charles; Prajapati, Vimal; Lansang, Perla; Turchin, Irina; Wiseman, Marni; Jack, Carolyn; Ramien, Michele; Purdy, Kerri; Grewal, Parbeer

doi:10.17632/z3vchf7yx6.1

Supplemental material - Treat-to-Target in the Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Canadian perspective

Published: 16 March 2023| Version 1 | DOI: 10.17632/z3vchf7yx6.1

Contributors:

Jensen Yeung, Melinda Gooderham, Chih-Ho Hong, Charles Lynde, Vimal Prajapati, Perla Lansang, Irina Turchin, Marni Wiseman, Carolyn Jack, Michele Ramien, Kerri Purdy, Parbeer Grewal

Description

Members of the Committee who developed this treat-to-target consensus on moderate-to-severe AD in adults.

Files

Funding

LEO Pharma

Supplemental material - Treat-to-Target in the Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Canadian perspective

Description

Files

Categories

Funding

Licence